Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.

The Journal of antimicrobial chemotherapy - 1 Feb 2003

Alós J I, Aracil B, Oteo J, Gómez-Garcés J L

Abstract excerpt

In 1998 we conducted a multicentre study in Spain on the susceptibility of Streptococcus pyogenes isolates to different 14-, 15- and 16-membered macrolides and clindamycin, in which the number of strains examined was proportional to the number of inhabitants in each geographical area. The aim of the present work was to re-examine the antimicrobial susceptibility of S. pyogenes in 2001, using the same methodology...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cephalosporins
Share to Clindamycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Erythromycin

Share to Microbial Sensitivity Tests

Share to Streptococcal Infections

Share to Streptococcus pyogenes

Source

Identifiers

PMID: 12562699
DOI: 10.1093/jac/dkg100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.PMID 12562699Read ↗

Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.Semantic proximity Read ↗

Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).Semantic proximity Read ↗

[Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].Semantic proximity Read ↗

Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil.Semantic proximity Read ↗

[Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)].Semantic proximity Read ↗

Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.Semantic proximity Read ↗

Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994–2006)Semantic proximity Read ↗

A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.Semantic proximity Read ↗

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.Semantic proximity Read ↗

Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.Semantic proximity Read ↗

What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.Semantic proximity Read ↗

[Antimicrobial resistance characteristics of clinical isolates of Streptococcus pyogenes].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.